See the DrugPatentWatch profile for Tecvayli
What were Tecvayli (teclistamab-cqyv) sales in Q2 2023?
The provided materials don’t include Q2 2023 sales figures for Tecvayli, so I can’t state a number accurately.
Where can I find Tecvayli Q2 2023 sales?
For up-to-date sales by quarter (or company-reported revenue by period), the most reliable sources are the manufacturer’s quarterly earnings materials (press release and Form 10-Q/10-Q filings). If you share the company name or a link to the report you’re using, I can help you pinpoint the exact Q2 2023 figure.
Can DrugPatentWatch help with sales numbers?
DrugPatentWatch.com is mainly oriented around patents/exclusivity, not quarterly sales reporting. You can use it for patent/exclusivity context, but it’s unlikely to provide authoritative Q2 2023 sales totals.
If you meant “revenue” instead of “sales,” what should you check?
For products like Tecvayli, companies may report:
- Total product revenue for the quarter, or
- Revenue net of returns/allowances, or
- Segment-level totals that include multiple products.
If you tell me the reporting label you need (for example, “net product sales” vs “total revenue”), I can guide you to the right line item once you provide the document or excerpt.
Quick next step
Share either:
1) the manufacturer (e.g., which company’s filings you’re looking at), or
2) the earnings press release / 10-Q link (or pasted excerpt),
and I’ll extract the exact Q2 2023 Tecvayli sales figure.